stonks4u
Sign up free
CPIX logo

CPIX Cumberland Pharmaceuticals Inc.

NASDAQ Global Select · Drug Manufacturers - Specialty & Generic · Healthcare

$7.79
-0.11 (-1.39%)

Cumberland Pharmaceuticals Inc. functions as a specialized pharmaceutical enterprise, primarily involved in the procurement, advancement, and commercialization of prescription medications. Its strategic focus areas include acute hospital care, gastroenterology, rheumatology, and oncology, with operations spanning both the United States and global markets. The company's existing product line includ…

Market Cap: $116.72Mwww.cumberlandpharma.com

Price (90d)

No price history yet — the daily price refresh runs once a day.

Signal Score (90d)

80
80
Aug 12Aug 12

Quote

Day Range
$7.74 – $8.03
52-Week Range
$1.85 – $8.45
Volume
$57.7K
Market Cap
$116.72M
50-Day Avg
$6.66
200-Day Avg
$4.42
Prev Close
$7.90
Open
$7.85

Valuation & Ratios

P/E Ratio
-20.95
EPS
$-0.19
P/B Ratio
2.39
P/S Ratio
1.34
Debt/Equity
0.41
Current Ratio
1.01
Dividend Yield
+0.0%
Gross Margin
+85.0%

Returns & Efficiency

Return on Equity
-11.4%
Return on Assets
-3.7%
FCF Yield
+8.1%
EV/EBITDA
19.70

Revenue & Net Income (Annual)

Fiscal YearRevenueNet IncomeEPS
2025$44.52M$-2.84M$-0.19
2024$37.87M$-6.48M$-0.46
2023$39.55M$-6.28M$-0.44
2022$42.01M$-5.57M$-0.38
2021$35.99M$-3.51M$-0.24

Social Signal Score

30
5d
30
1 mentions
—
30d
30
1 mentions
—
60d
30
1 mentions
—
90d
30
1 mentions
—
news: 1

Earnings

Tue, Nov 3(in 3 months)

Consensus estimate $-0.13 per share

5of 6 quarters beat consensus

Typical surprise +67.8% (median, so one quarter with a near-zero estimate can't distort it)

  • Tue, Aug 4$-0.20 vs $-0.13miss
  • Tue, May 5$-0.13 vs $-0.13beat
  • Tue, Mar 3$-0.01 vs $-0.13beat
  • Tue, Nov 4$-0.06 vs $-0.13beat
  • Tue, May 6$0.16 vs $-0.01beat
  • Tue, Mar 4$-0.02 vs $-0.11beat

Estimates and results for CPIX via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.

Valuation

CPIXhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.

Mentions (1)

  • Newsdefenseworld.net·3d ago·Negative

    Cumberland Pharmaceuticals (NASDAQ:CPIX) Share Price Passes Above Two Hundred Day Moving Average – Should You Sell? Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX - Get Free Report) passed above its 200-day moving average during trading on Tuesday. The stock has a 200-day moving average of $4.87 and traded as high as $8.15. Cumberland Pharmaceuticals shares last traded at $7.96, with a volume of 79,334 shares traded. Analysts Set New Price Targets CPIX has

    View source ↗